UK-based Venture Life Group PLC (VLG) has acquired three products positioned for oncology support from Helsinn Healthcare SA for CHF6.0m ($6.5m).
Two of the products – Gelclair and Xonrid – are registered as self-care medical devices but distributed through healthcare professionals,...








